← Leaderboards
Yuan-Ping Han
University Of Southern California
$2,564,311
Attributed
$2,564,311
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $527.5K · FY2005–08$1M$750K$500K$250K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$2,564,311 · 2
By mechanism
R01$2,564,311 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Laurie D Deleve$11,554,929
Others in their field
Top investigators on “Extracellular Matrix”
- Valerie Marie Weaver · University Of California, San Francisco$23,238,959
- Naftali Kaminski · Yale University$23,053,857
- Kristiina Vuori · Burnham Institute For Medical Research$21,402,128
- Paul Wesley Noble · Yale University$20,772,493
- Martin A. Schwartz · Yale University$19,622,975
- Buddy D Ratner · University Of Washington$19,514,039
Research focus
Extracellular MatrixInflammationChymotrypsinBasePeptide HydrolasesSignal TransductionMatrix MetalloproteinasesLiverHepatocyteSourceMediatingMolecularPreventResponseEndopeptidasesGelatinase BCellsChronicSkinInjuryProtease InhibitorIntegrinsKeratinocyteFibrogenesis
Grant awards (10)
Hepatic Stellate Cell Derived MMP9 in Liver Fibrogenesis$284,750
R01 · FY2008 · DK · contact PI
ACT,a pathophysiological inhibitor of MMP-9 activation$206,746
R01 · FY2008 · AR · contact PI
Hepatic Stellate Cell Derived MMP9 in Liver Fibrogenesis$290,561
R01 · FY2007 · DK · contact PI
ACT,a pathophysiological inhibitor of MMP-9 activation$210,966
R01 · FY2007 · AR · contact PI
Hepatic Stellate Cell Derived MMP9 in Liver Fibrogenesis$299,239
R01 · FY2006 · DK · contact PI
ACT,a pathophysiological inhibitor of MMP-9 activation$217,266
R01 · FY2006 · AR · contact PI
Hepatic Stellate Cell Derived MMP9 in Liver Fibrogenesis$305,657
R01 · FY2005 · DK
ACT,a pathophysiological inhibitor of MMP-9 activation$221,813
R01 · FY2005 · AR
Hepatic Stellate Cell Derived MMP9 in Liver Fibrogenesis$305,500
R01 · FY2004 · DK
ACT,a pathophysiological inhibitor of MMP-9 activation$221,813
R01 · FY2004 · AR